Cambodia Investment Review
A landmark agreement has announced between The Royal Group of Companies (Cambodia), Fresh Start (Australia), and Aegros (Australia), outlining a joint venture that aims not only to revolutionize Plasma treatment products across the ASEAN region but also to play a significant role in advancing Cambodia’s healthcare industry.
The Joint Venture, named Royal Group Plasma Fractionation, represents a next step in healthcare innovation, especially for Cambodia. It encompasses the collection of Plasma throughout Asia, the establishment of a $400 million plasma fractionation facility in Singapore capable of processing 1 million liters per year, and the building of a Fill & Finish facility in Cambodia.
Milestone for Cambodia & regions healthcare center
The initiative’s profound impact on Cambodia is manifold. It marks a critical advancement in the nation’s healthcare industry, aligning with the broader vision of modernization and providing crucial resources for life-saving treatments. These include applications in cancer therapy, hemophilia management, and other vital medical services.
Neak Oknha Kith Meng, Chairman and CEO of Royal Group, hailed the venture as a “promising milestone in the area of Health development not only for Cambodia but for the ASEAN Region.” He emphasized the opportunity for Cambodia to become an integral part of Plasma products across ASEAN and Asia, thanking Cambodia’s Prime Minister and his Joint Venture Partners for their support and confidence.
![](/wp-content/uploads/2023/08/photo_2023-08-03_15-53-37-1024x682-1.jpg")
In his remarks, Daniel Phillips, CEO of Fresh Start Australia, shared his passion for making a sustainable difference in communities. He stated, “The world, especially Asia, has a shortage of Plasma products which is impacting the wellbeing of so many individuals across all counties.” He stressed the innovative technology of Aegros, affordability, job creation, and his impression of Cambodia’s opportunities, culture, and people.
Improving accessibility & quality of care
Cambodia’s healthcare system has long faced challenges in accessibility and quality of care. This Joint Venture signifies a major stride in addressing these issues, leveraging Cambodia’s strategic position to foster industry growth, create employment, and enhance the country’s medical capabilities.
The Royal Group, known for its diverse business conglomerate, and Aegros Limited, a market innovator in health, jointly with Fresh Start Australia, have set the stage for a transformative collaboration. This venture is not merely a business investment but a humanitarian endeavor that resonates with Cambodia’s aspirations for healthcare development and regional leadership.
As Cambodia continues to experience economic growth and development, the collaboration with Fresh Start Australia and Aegros symbolizes an essential step in elevating healthcare standards and accessibility for the Cambodian people.
